Komori
Changes in Officers4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice of Changes to Directors’ Assigned Responsibilities

Human Capital Strategy has been newly added to Mori Maiko (森麻衣子)’s responsibilities. There is no change to the directors’ titles or number.

Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 4 November 2026

Incoming appointee

1 item
Scheduled Appointment Date4 November 2026
Mori Maiko (森 麻衣子)
Previous positionDirector and Senior Managing Executive Officer
New positionDirector and Managing Executive Officer, Human Capital Strategy
Directors after the change13Number
Reason for change

A director responsible for promoting the Group’s human capital strategy will be appointed.

Who is moving to which position
ItemDetails
Resolution date4 November 2026
Scheduled Appointment Date4 November 2026
Name of appointeeMori Maiko (森 麻衣子)
Appointee's new positionDirector and Managing Executive Officer, Human Capital Strategy
Appointee's previous positionDirector and Senior Managing Executive Officer
Reason for changeA director responsible for promoting the Group’s human capital strategy will be appointed.
Number of directors after the change13 (including 4 outside directors)
Items this document does not state (14)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To promote the human capital strategy of the Group.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.